Adero Partners’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $35K | Hold |
3,433
| – | – | ﹤0.01% | 258 |
|
|
2024
Q4 | $47.9K | Hold |
3,433
| – | – | ﹤0.01% | 258 |
|
|
2024
Q3 | $67K | Hold |
3,433
| – | – | ﹤0.01% | 235 |
|
|
2024
Q2 | $63.9K | Hold |
3,433
| – | – | ﹤0.01% | 213 |
|
|
2024
Q1 | $48.1K | Hold |
3,433
| – | – | ﹤0.01% | 202 |
|
|
2023
Q4 | $29.1K | Hold |
3,433
| – | – | ﹤0.01% | 192 |
|
|
2023
Q3 | $30.7K | Hold |
3,433
| – | – | ﹤0.01% | 181 |
|
|
2023
Q2 | $29.6K | Hold |
3,433
| – | – | ﹤0.01% | 165 |
|
|
2023
Q1 | $36.2K | Hold |
3,433
| – | – | ﹤0.01% | 160 |
|
|
2022
Q4 | $116K | Hold |
3,433
| – | – | 0.01% | 157 |
|
|
2022
Q3 | $184K | Hold |
3,433
| – | – | 0.02% | 148 |
|
|
2022
Q2 | $182K | Hold |
3,433
| – | – | 0.03% | 147 |
|
|
2022
Q1 | $278K | Hold |
3,433
| – | – | 0.04% | 135 |
|
|
2021
Q4 | $696K | Hold |
3,433
| – | – | 0.11% | 76 |
|
|
2021
Q3 | $925K | Hold |
3,433
| – | – | 0.17% | 60 |
|
|
2021
Q2 | $884K | Hold |
3,433
| – | – | 0.2% | 53 |
|
|
2021
Q1 | $1.03M | Hold |
3,433
| – | – | 0.46% | 40 |
|
|
2020
Q4 | $876K | Buy |
+3,433
| New | +$876K | 0.75% | 28 |
|